Year: 2021
Type: article
Abstract: This special issue was conceived with the intent of highlighting the use of existing and progressive technologies in hit discovery and how these technologies may be combined to generate vital hits for drug discovery. These aspects now cross both small-molecule and large-molecule discovery in many organizations. In addition, the issue is intended to remind readers of the heritage of SLAS journals, and how they have supported the use and application of innovative hit identification approaches.
Source: SLAS DISCOVERY
Authors: Mark Wigglesworth, Peter Hodder
Institutions: AstraZeneca (United Kingdom), Amgen (United States)
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W3124489731